Lab Notes: a blog by Trials.ai

The Past and Future of Clinical Trials – Part III

By Fuad Rahman | June 17, 2019 |
Posted in , ,

Where can AI impact the clinical trials process directly? Application areas include increasing trial efficiency through better protocol design, patient enrollment and retention, and study start-up, which were each named as prime candidates for improvement by nearly 40% of sponsors in a recent ICON-Pharma Intelligence survey. With clinical trials accounting for 40% of pharma research…

Continue Reading This Post

The Past and Future of Clinical Trials – Part IV

By Fuad Rahman | June 9, 2019 |
Posted in ,

At last year’s Healthcare Information and Management Systems Society conference (HIMSS 2018), Mayo Clinic announced that it increased enrollment by 80% by using IBM’s Watson AI platform for breast cancer. Dr. Kyu Rhee, chief health officer at Watson Heath, further stated, “Watson for clinical trial matching understands key patient attributes and how to identify them in a…

Continue Reading This Post

The Past and Future of Clinical Trials – Part II

By Fuad Rahman | May 29, 2019 |
Posted in

An effective trial needs to be patient-centric, with solid study design and execution, supported by real-time analytics. It should also have good patient input and provide insights to the sponsor.  Designing, conducting, executing, and reporting on clinical trials involves many complex issues. These issues include, but are not limited to, the duration of the trial,…

Continue Reading This Post

The Past and Future of Clinical Trials – Part I

By Fuad Rahman | May 20, 2019 |
Posted in

Today is a very important day on our calendar – it’s International Clinical Trials Day, May the 20th. Dr. James Lind is recognized as the first physician to have conducted a controlled clinical trial in the modern era. Lind was a Scottish naval surgeon and worked on British Royal Navy ships in the 16th century. He noticed…

Continue Reading This Post

Trials.ai joins JLABS!

By Kim Walpole | March 15, 2019 |
Posted in

We are excited to announce that Trials.ai is now a resident company of Johnson & Johnson Innovation, JLABS San Diego, a premier life science incubator program. JLABS is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-enhancing health and wellness solutions to patients around the world.  As…

Continue Reading This Post

Trials.ai Presents at Nex Cubed Winter Showcase

By Kim Walpole | February 2, 2018 |
Posted in

A packed out crowd gathered with excitement at the Sway / Nex Cubed headquarters in the SF financial district for the Nex Cubed winter showcase. Momentarily, Kelsey Morgan, co-founder of Nex Cubed would unveil the latest cohort of incubating companies. Nex Cubed is a frontier tech investment firm that, among other things, operates an incubator for early stage technology companies. Kelsey shared…

Continue Reading This Post